MinDNA technology allows for the analysis of DNA in one minute, and has been applied in the development of the rapid white blood cell count and absolute neutrophil count assays that monitor a side effect of the Novartis drug clozaril
Weight gain: Clozaril
, Zyprexa, and Seroquel are the most likely to cause weight gain, while Risperdal (risperidone), Geodon (ziprasidone), and Abilify (aripiprazole) have fewer weight-related side effects.
Research by the International Suicide Prevention Trial showed that the anti-psychotic treatment Clozaril
can significantly reduce suicide attempts.
The study showed that treatment with Clozaril
significantly reduced the risk of suicidal behaviour in these people, over and above another common form of treatment.
Some commonly prescribed medications: Haldol, Thorazine, Clozaril
The most publicized of these was Clozaril
(clozapine), manufactured by Sandoz Pharmaceutical Corporation, which allows many patients to lead a reasonably normal life.
The best example of the last problem is the absence of Clozaril
from the CDC formulary.
Antidepressants -- Elvail/Endep*, Aventyl/Panelor, Vivactyl, Tofranil/SK Pramine, Norpramin/Pertofrane, Sinequan/Adapin, Ascendin, Ludiomil, Prozac, Wellbutrin, Surmontil, lithium, Clozaril
His arms and neck were scarred from self-mutilation and a suicide attempt, and he was heavily medicated with Clozaril
Elavil/Endep(*), Aventyl/Pamelor, Vivactyl, Tofranil/SKPramine, Norpramin/Pertofrane, Sinequan/Adapin, Ascendin, Ludiomil, Prozac, Zoloft, Paxil, Wellbutrin, Surmontil, lithium, Clozaril
The medication will be sold under the trade name Clozaril
by Sandoz Pharmaceutical Corp.
sales for Clozaril
and its generic equivalent clozapine were $135.
31, 2009, according to IMS Health, complement Mylan's already approved and marketed strengths, which are therapeutically equivalent to Novartis' antipsychotic Clozaril
25 mg and 100 mg.
sales for Clozaril
and its generic equivalent, clozapine were $182 million for 2004.
At Alamo, he created a fully integrated commercial pharmaceutical company to market Fazaclo, a reformulation of Novartis' anti-psychotic drug, Clozaril